BNB Plus Corp - Company Profile
Powered by 
All the sales intelligence you need on BNB Plus Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how BNB Plus Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with BNB Plus Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
BNB Plus Corp (BNB), formerly Applied DNA Sciences Inc, is a biotechnology company that focuses on the development and commercialization of technologies for DNA and RNA production and detection. The company offers enzymatic manufacture of synthetic DNA, molecular diagnostics, and genetic testing services, as well as DNA tagging for supply chain security. Its major products and services encompass the production of nucleic acid-based therapeutics, enterprise-scale diagnostic testing solutions, and supply chain authentication technologies. The company's products and services are utilized by customers in industries such as healthcare, pharmaceuticals, and manufacturing, supporting applications in therapeutics, diagnostics, and supply chain integrity. BNB is headquartered in Stony Brook, New York, the US.
Headquarters
United States of America
Address
50 Health Sciences Drive, Stony Brook, New York, 11790
Website
www.bnbx.io
Telephone
1 631 2408800
No of Employees
26
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
BNBX (OTC)
Revenue (2024)
$2.1M
1.1%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
-116.8%
(2024 vs 2023)
Market Cap*
$1.0M
Net Profit Margin (2024)
XYZ
-114.4%
(2024 vs 2023)
* As of and is in US$
BNB Plus Corp premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Therapeutic DNA Production | Linea |
| Enterprise-Scale Diagnostic Testing Solutions | |
| DNA Tagging and Security Products |
Competitor Comparison
| Key Parameters | BNB Plus Corp | Novartis AG | MaxCyte Inc | Touchlight Genetics Ltd | 4basebio Plc |
|---|---|---|---|---|---|
| Headquarters | United States of America | Switzerland | United States of America | United Kingdom | United Kingdom |
| City | Stony Brook | Basel | Rockville | London | Cambridge |
| State/Province | New York | Basel-Stadt | Maryland | England | Cambridgeshire |
| No. of Employees | 26 | 75,267 | 91 | 136 | - |
| Entity Type | Public | Public | Public | Private | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| James A. Hayward, PhD | President; Chairman; Chief Executive Officer | Executive Board | 2006 | - |
| Beth Jantzen | Chief Financial Officer | Senior Management | 2015 | - |
| Judith Murrah | Chief Operating Officer | Senior Management | 2021 | - |
| Clay Shorrock | Chief Legal Officer; Director - Executive- Business Development | Senior Management | - | - |
| Bob Catell | Director | Non Executive Board | 2016 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer